Revelation Biosciences (REVB) News Today $4.26 -0.14 (-3.16%) Closing price 02/21/2025 03:55 PM EasternExtended Trading$4.12 -0.15 (-3.43%) As of 02/21/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period REVB Start 1B Trial and Announces SplitJanuary 29, 2025 | msn.comRevelation Biosciences Inc trading halted, news pendingJanuary 27, 2025 | markets.businessinsider.comRevelation Biosciences announces 1-for-16 reverse stock splitJanuary 24, 2025 | markets.businessinsider.comRevelation Biosciences stock hits 52-week low at $0.28January 24, 2025 | msn.comRevelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025January 24, 2025 | businesswire.comRevelation Biosciences starts Phase 1b clinical study of Gemini in CKDJanuary 22, 2025 | markets.businessinsider.comRevelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD PatientsJanuary 21, 2025 | businesswire.comRevelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025January 13, 2025 | businesswire.comNasdaq Grants Revelation Biosciences Inc. Continued ListingJanuary 6, 2025 | finance.yahoo.comRevelation Biosciences (REVB) Receives a Buy from Roth MKMDecember 8, 2024 | markets.businessinsider.comRevelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross ProceedsDecember 3, 2024 | businesswire.comREVB Gets FDA Go AheadDecember 2, 2024 | msn.comRevelation Biosciences Inc. Announces FDA Acceptance of Gemini INDDecember 2, 2024 | businesswire.comRevelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug SupplyNovember 12, 2024 | businesswire.comRevelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024November 8, 2024 | businesswire.comRevelation Biosciences files for secondary offering of about 5.1M sharesSeptember 3, 2024 | msn.comRevelation Biosciences, Inc. (REVBW)August 22, 2024 | ca.finance.yahoo.comRevelation Biosciences (NASDAQ:REVB) Stock, Short Interest ReportAugust 21, 2024 | benzinga.comRevelation Biosciences (NASDAQ:REVB) Stock Quotes, Forecast and News SummaryAugust 21, 2024 | benzinga.comRevelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross ProceedsAugust 21, 2024 | finance.yahoo.comREVB: Bolsters Cash Amid Positive Trial ResultsAugust 12, 2024 | finance.yahoo.comRevelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024August 9, 2024 | businesswire.comRevelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker ActivityJune 24, 2024 | businesswire.comRevelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of GeminiJune 13, 2024 | businesswire.comREVB Stock Earnings: Revelation Biosciences Misses EPS for Q1 2024May 10, 2024 | investorplace.comRevelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024May 10, 2024 | businesswire.comRevelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023March 22, 2024 | businesswire.comRevelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)March 13, 2024 | finance.yahoo.comRevelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of GeminiMarch 4, 2024 | finance.yahoo.comRevelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)February 13, 2024 | finance.yahoo.comRevelation Biosciences Secures $6.2M in Public OfferingFebruary 9, 2024 | msn.comRevelation Biosciences Inc. Announces Closing of $6.2 Million Public OfferingFebruary 5, 2024 | finance.yahoo.comTrading was temporarily halted for "REVB" at 02:02 PM with a stated reason of "LULD pause." Trading set to resume at 02:02 PM. February 5, 2024 | marketbeat.comRevelation Biosciences Shares Slide Premarket on Public OfferingFebruary 2, 2024 | marketwatch.comRevelation Biosciences to raise ~$6.2M through public offering of sharesFebruary 1, 2024 | msn.comWhy Is Revelation Biosciences (REVB) Stock Down 62% Today?February 1, 2024 | investorplace.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comRevelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)January 30, 2024 | finance.yahoo.comFATE, NEXI and INBS among mid-day moversJanuary 29, 2024 | seekingalpha.comTrading was temporarily halted for "REVB" at 11:01 AM with a stated reason of "LULD pause." Trading set to resume at 11:01 AM. January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 10:01 AM with a stated reason of "LULD pause." Trading set to resume at 11:01 AM. January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 10:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 10:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 10:01 AM with a stated reason of "LULD pause." Trading set to resume at 10:01 AM. January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comREVB Continues March to TrialsJanuary 26, 2024 | finance.yahoo.com Get Revelation Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for REVB and its competitors with MarketBeat's FREE daily newsletter. Email Address REVB Media Mentions By Week REVB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REVB News Sentiment▼0.000.60▲Average Medical News Sentiment REVB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REVB Articles This Week▼00▲REVB Articles Average Week Get Revelation Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for REVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Syros Pharmaceuticals News Today 180 Life Sciences News Today Artelo Biosciences News Today GRI Bio News Today Polyrizon News Today Bio-Path News Today Sonoma Pharmaceuticals News Today Genprex News Today Purple Biotech News Today Synaptogenix News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REVB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revelation Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revelation Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
